The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Human Monoclonal Antibodies Directed against Toxins A and B Prevent Clostridium difficile -Induced Mortality in Hamsters
Open accessAbstract
Clostridium difficile is the leading cause of nosocomial antibiotic-associated diarrhea, and recent outbreaks of strains with increased virulence underscore the importance of identifying novel approaches to treat and prevent relapse of Clostridium difficile- associated diarrhea (CDAD). CDAD pathology is induced by two exotoxins, toxin A and toxin B, which have been shown to be cytotoxic and, in the case of toxin A, enterotoxic. In this report we describe fully human monoclonal antibodies (HuMAbs) that neutralize these toxins and prevent disease in hamsters. Transgenic mice carrying human immunoglobulin genes were used to isolate HuMAbs that neutralize the cytotoxic effects of either toxin A or toxin B in cell-based in vitro neutralization assays. Three anti-toxin A HuMAbs (3H2, CDA1, and 1B11) could all inhibit the enterotoxicity of toxin A in mouse intestinal loops and the in vivo toxicity in a systemic mouse model. Four anti-toxin B HuMAbs (MDX-1388, 103-174, 1G10, and 2A11) could neutralize cytotoxicity in vitro, although systemic toxicity in the mouse could not be neutralized. Anti-toxin A HuMAb CDA1 and anti-toxin B HuMAb MDX-1388 were tested in the well-established hamster model of C. difficile disease. CDA1 alone resulted in a statistically significant reduction of mortality in hamsters; however, the combination treatment offered enhanced protection. Compared to controls, combination therapy reduced mortality from 100% to 45% ( P < 0.0001) in the primary disease hamster model and from 78% to 32% ( P < 0.0001) in the less stringent relapse model.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Epidemic, Toxin Gene–Variant Strain of Clostridium difficile
McDonald, L. C., Killgore, G. E., Thompson, A., Owens, R. C., Kazakova, S. V., Sambol, S. P., Johnson, S., & Gerding, D. N. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051590 · Cited by 2,006
Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia
Bartlett, J. G., Chang, T. W., Gurwith, M., Gorbach, S. L., & Onderdonk, A. B. (1978) · New England Journal of Medicine · doi:10.1056/nejm197803092981003 · Cited by 1,374
Nosocomial Acquisition of Clostridium difficile Infection
McFarland, L. V., Mulligan, M. E., Kwok, R. Y. Y., & Stamm, W. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198901263200402 · Cited by 1,326
Antibiotic-Associated Diarrhea
Bartlett, J. G. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp011603 · Cited by 1,197
Clostridium difficile Toxins: Mechanism of Action and Role in Disease
Voth, D. E., & Ballard, J. D. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.2.247-263.2005 · Cited by 1,104
Glucosylation of Rho proteins by Clostridium difficile toxin B
Just, I., Selzer, J., Wilm, M., Eichel-Streiber, C. V., Mann, M., & Aktories, K. (1995) · Nature · doi:10.1038/375500a0 · Cited by 1,032
Asymptomatic Carriage of Clostridium difficile and Serum Levels of IgG Antibody against Toxin A
Kyne, L., Warny, M., Qamar, A., & Kelly, C. P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420604 · Cited by 935
Kyne, L., Warny, M., Qamar, A., & Kelly, C. P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03592-3 · Cited by 804
Fulminant Clostridium difficile: An Underappreciated and Increasing Cause of Death and Complications
Dallal, R. M., Harbrecht, B. G., Boujoukas, A. J., Sirio, C. A., Farkas, L. M., Lee, K. K., & Simmons, R. L. (2002) · Annals of Surgery · doi:10.1097/00000658-200203000-00008 · Cited by 628
Muto, C. A., Pokrywka, M., Shutt, K., Mendelsohn, A. B., Nouri, K., Posey, K., Roberts, T., Croyle, K., Krystoflak, S., Patel-Brown, S., et al. (2005) · Infection Control & Hospital Epidemiology · doi:10.1086/502539 · Cited by 619
The Enterotoxin from Clostridium difficile (ToxA) Monoglucosylates the Rho Proteins
Just, I., Wilm, M., Selzer, J., Rex, G., von Eichel-Streiber, C., Mann, M., & Aktories, K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.23.13932 · Cited by 478
Clindamycin-Associated Colitis Due to a Toxin-Producing Species of Clostridium in Hamsters
Bartlett, J. G., Onderdonk, A. B., Cisneros, R. L., & Kasper, D. L. (1977) · Journal of Infectious Diseases · doi:10.1093/infdis/136.5.701 · Cited by 472
Nosocomial Clostridium difficile colonisation and disease
Johnson, S., Clabots, C. R., Linn, F. V., Olson, M. M., Peterson, L. R., Gerding, D. N., Johnson, S., Linn, F. V., Peterson, L. R., & Gerding, D. N. (1990) · The Lancet · doi:10.1016/0140-6736(90)91605-a · Cited by 340
Comparison of two toxins produced by Clostridium difficile
Taylor, N. S., Thorne, G. M., & Bartlett, J. G. (1981) · Infection and Immunity · doi:10.1128/iai.34.3.1036-1043.1981 · Cited by 294
Leung, D. Y. M., Kelly, C. P., Boguniewicz, M., Pothoulakis, C., LaMont, J. T., & Flores, A. (1991) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)83393-1 · Cited by 278
Intravenous immunoglobulin therapy for severe Clostridium difficile colitis
Salcedo, J., Keates, S., Pothoulakis, C., Warny, M., Castagliuolo, I., LaMont, J. T., & Kelly, C. P. (1997) · Gut · doi:10.1136/gut.41.3.366 · Cited by 264
Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea
Sougioultzis, S., Kyne, L., Drudy, D., Keates, S., Maroo, S., Pothoulakis, C., Giannasca, P. J., Lee, C. K., Warny, M., Monath, T. P., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.004 · Cited by 260
Differential effects of Clostridium difficile toxins A and B on rabbit ileum
Triadafilopoulos, G., Pothoulakis, C., O'Brien, M. J., & LaMont, J. T. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)91014-6 · Cited by 204
Wilcox, M. H. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh176 · Cited by 200
McEllistrem, M. C., Carman, R. J., Gerding, D. N., Genheimer, C. W., & Zheng, L. (2005) · Clinical Infectious Diseases · doi:10.1086/427113 · Cited by 173
Comparative sequence analysis of theClostridium difficile toxins A and B
von Eichel-Streiber, C., Laufenberg-Feldmann, R., Sartingen, S., Schulze, J., & Sauerborn, M. (1992) · Molecular and General Genetics MGG · doi:10.1007/bf00587587 · Cited by 159
Kink, J. A., & Williams, J. A. (1998) · Infection and Immunity · doi:10.1128/iai.66.5.2018-2025.1998 · Cited by 159
Hofmann, F., Busch, C., Prepens, U., Just, I., & Aktories, K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.17.11074 · Cited by 159
Kim, P. H., Iaconis, J. P., & Rolfe, R. D. (1987) · Infection and Immunity · doi:10.1128/iai.55.12.2984-2992.1987 · Cited by 136
Lyerly, D. M., Bostwick, E. F., Binion, S. B., & Wilkins, T. D. (1991) · Infection and Immunity · doi:10.1128/iai.59.6.2215-2218.1991 · Cited by 136
Colitis Induced by Clostridium difficile
Bartlett, J. G., Chang, T.-W., Taylor, N. S., & Onderdonk, A. B. (1979) · Clinical Infectious Diseases · doi:10.1093/clinids/1.2.370 · Cited by 127
Torres, J. F., Lyerly, D. M., Hill, J., & Monath, T. P. C. (1995) · Infection and Immunity · doi:10.1128/iai.63.12.4619-4627.1995 · Cited by 117
Kyne, L., Farrell, R. J., & Kelly, C. P. (2001) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(05)70209-0 · Cited by 114
Giannasca, P. J., Zhang, Z., Lei, W.-D., Boden, J. A., Giel, M. A., Monath, T. P. C., & Thomas, W. D. (1999) · Infection and Immunity · doi:10.1128/iai.67.2.527-538.1999 · Cited by 113
Self-citationCorthier, G., Muller, M. C., Wilkins, T. D., et al. (1991) · Infection and Immunity · doi:10.1128/iai.59.3.1192-1195.1991 · Cited by 111
Antimicrobial agents implicated in Clostridium difficile toxin-associated diarrhea of colitis.
Bartlett, J. G. (1981) · PubMed · Cited by 108
Kelly, C. P., Pothoulakis, C., Vavva, F., Castagliuolo, I., Bostwick, E. F., O’Keane, J. C., Keates, S. E., & LaMont, J. T. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.2.373 · Cited by 97
Clark, G. F., Krivan, H. C., Wilkins, T. D., & Smith, D. F. (1987) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(87)90561-3 · Cited by 71
Partial Purification and Characterization of a Cytotoxin from Clostridium difficile
Taylor, N. S., & Bartlett, J. G. (1979) · Clinical Infectious Diseases · doi:10.1093/clinids/1.2.379 · Cited by 60
Clostridium difficile-associated diarrhoea: epidemiological data from Western Australia
Riley, T. V., O'Neill, G. L., Bowman, R. A., & Golledge, C. L. (1994) · Epidemiology and Infection · doi:10.1017/s0950268800051414 · Cited by 49
Active and passive immunization to protect against antibiotic associated caecitis in hamsters.
Fernie, D. S., Thomson, R. O., Batty, I., & Pd, W. (1983) · PubMed · Cited by 44
Clark, G. F., Krivan, H. C., Wilkins, T. D., & Smith, D. F. (1987) · Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States) · Cited by 17
Cited by
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection
Wilcox, M. H., Gerding, D. N., Poxton, I. R., Kelly, C., Nathan, R., Birch, T., Cornely, O. A., Rahav, G., Bouza, E., Lee, C., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1602615 · Cited by 858
Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance
Dickey, S. W., Cheung, G. Y. C., & Otto, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.23 · Cited by 799
Treatment with Monoclonal Antibodies against Clostridium difficile Toxins
Lowy, I., Molrine, D. C., Leav, B. A., Blair, B. M., Baxter, R., Gerding, D. N., Nichol, G., Thomas, W. D., Leney, M., Sloan, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907635 · Cited by 746
Self-citationA mouse model of clostridium difficile-associated disease
Chen, X., Katchar, K., Goldsmith, J. D., Nanthakumar, N., Cheknis, A., Gerding, D. N., & Kelly, C. P. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.09.002 · Cited by 510
Clostridium difficile binary toxin CDT: Mechanism, epidemiology, and potential clinical importance
Gerding, D. N., Johnson, S., Rupnik, M., & Aktories, K. (2014) · Gut Microbes · doi:10.4161/gmic.26854 · Cited by 416
Metadata
- Authors
- Babcock, G. J., Broering, T. J., Hernandez, H. J., Mandell, R. B., Donahue, K., Boatright, N., Stack, A. M., Lowy, I., Graziano, R., Molrine, D., Ambrosino, D. M., & Thomas, W. D.
- Venue
- Infection and Immunity
- Publisher
- American Society for Microbiology
- Published
- 2006-11
- Volume
- 74
- Issue
- 11
- Pages
- 6339-6347
- ISSN
- 0019-9567 (ISSN-L)
- 1098-5522
- OpenAlex
- W2108975442
- Cited by
- 257
- References
- 38
- FWCI
- 7.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.